Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tilray (TSE:TLRY)
TSX:TLRY
Tilray (TLRY) Stock Price & Analysis
292 Followers
TLRY Stock Chart & Stats
Day’s RangeC$2.42 - C$2.6
52-Week Range― - ―
Previous CloseC$2.47
Volume1.96M
Average Volume (3M)N/A
Market Cap
$1.90B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Jul 24, 2024EPS Estimate
-C$0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$3.09Price Target Upside21.23% Upside
Rating ConsensusHold
Number of Analyst Covering8
Tilray News
Bulls Say, Bears Say
Bulls Say
Cannabis SalesCannabis net sales have exceeded anticipations, indicating a stronger market position.
EarningsTilray's second quarter financial performance showcases a net revenue surpassing analyst expectations.
Sales GrowthImpressive sales growth in constant currency terms significantly outpaces analyst projections.
Bears Say
Earnings PerformanceAdjusted EBITDA missed analyst's expectations.
Profitability ConcernsBeverage alcohol adjusted gross margin was significantly reduced due to recent craft brand acquisitions.
Quarterly ResultsThe company reported a slight miss in their Q2 financial results.
---
Options Prices
Currently, No data available
---
Ownership Overview
1.47% Insiders
0.58% Mutual Funds
3.87% Other Institutional Investors
94.08% Public Companies and
Individual Investors
TLRY FAQ
What was Tilray’s price range in the past 12 months?
Currently, no data Available
What is Tilray’s market cap?
Currently, no data Available
When is Tilray’s upcoming earnings report date?
Tilray’s upcoming earnings report date is Jul 24, 2024 which is in 96 days.
How were Tilray’s earnings last quarter?
Tilray released its earnings results on Apr 09, 2024. The company reported -C$0.166 earnings per share for the quarter, missing the consensus estimate of -C$0.069 by -C$0.097.
Is Tilray overvalued?
According to Wall Street analysts Tilray’s price is currently Undervalued.
Does Tilray pay dividends?
Tilray does not currently pay dividends.
What is Tilray’s EPS estimate?
Tilray’s EPS estimate is -C$0.04.
How many shares outstanding does Tilray have?
Currently, no data Available
What happened to Tilray’s price movement after its last earnings report?
Tilray reported an EPS of -C$0.166 in its last earnings report, missing expectations of -C$0.069. Following the earnings report the stock price went down -20.286%.
Which hedge fund is a major shareholder of Tilray?
Among the largest hedge funds holding Tilray’s share is Aristeia Capital LLC. It holds Tilray’s shares valued at 229K.
---
Tilray Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
C$3.09 (21.23% Upside)
C$3.09 (21.23% Upside)
Blogger Sentiment
Bullish
TSE:TLRY Sentiment 63%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 991.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $20.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 7.1%
Last 30 Days ▼ 7.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-24.89%
12-Months-Change
Fundamentals
Return on Equity
-10.41%
Trailing 12-Months
Asset Growth
-3.73%
Trailing 12-Months
Company Description
Tilray
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.
---
TLRY Earnings Call
Q3 2024
0:00 / 0:00
---
TLRY Stock 12 Months Forecast
Average Price Target
C$3.09
▲(21.23% Upside)
Technical Analysis
Best Analysts Covering TLRY
1 Year
1 Year Success Rate
0/19 ratings generated profit
1 Year Average Return
-47.51%
reiterated a buy rating 3 months ago
Copying Vivien Azer's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -47.51% per trade.
---